The non-vitamin K antagonist oral anticoagulants (NOACs) do not require routine anticoagulation monitoring and have fewer interactions with food and other drugs compared with warfarin.4
However, patients taking a NOAC require their kidney function to be monitored throughout treatment.5
It is still also essential to check for potentially harmful drug interactions, contraindications and other patient-related safety factors (such as risk of falls and medicine non-compliance).5
Key questions to consider in patients taking a NOAC include:5
- Were kidney and liver function assessed when the patient started their NOAC?
- Has kidney function been checked in the last year?
- Have clinical circumstances or medicines changed?
- Has kidney function deteriorated, requiring more frequent monitoring?
For related information summaries, see NOAC indications and PBS listings and NOAC metabolism and interactions.